Goldman Sachs’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$37.1M Buy
1,593,383
+471,412
+42% +$10.2M ﹤0.01% 1821
2025
Q4
$22.4M Sell
1,121,971
-82,491
-7% -$1.61M ﹤0.01% 2276
2025
Q3
$22M Sell
1,204,462
-266,034
-18% -$5.19M ﹤0.01% 2163
2025
Q2
$29.5M Buy
1,470,496
+115,402
+9% +$2.22M ﹤0.01% 1769
2025
Q1
$24.6M Sell
1,355,094
-386,684
-22% -$6.93M ﹤0.01% 1831
2024
Q4
$30.2M Buy
1,741,778
+579,904
+50% +$11.1M ﹤0.01% 1732
2024
Q3
$22.4M Buy
1,161,874
+251,431
+28% +$4.63M ﹤0.01% 1962
2024
Q2
$14.9M Buy
910,443
+42,233
+5% +$655K ﹤0.01% 2124
2024
Q1
$13.2M Sell
868,210
-163,421
-16% -$2.57M ﹤0.01% 2214
2023
Q4
$16.5M Buy
1,031,631
+13,781
+1% +$193K ﹤0.01% 2083
2023
Q3
$13.2M Sell
1,017,850
-1,692
-0.2% -$22K ﹤0.01% 2157
2023
Q2
$13M Buy
1,019,542
+524,846
+106% +$6.57M ﹤0.01% 2207
2023
Q1
$5.57M Sell
494,696
-224,669
-31% -$2.73M ﹤0.01% 2968
2022
Q4
$9.53M Sell
719,365
-354,138
-33% -$4.66M ﹤0.01% 2637
2022
Q3
$12.5M Sell
1,073,503
-50,898
-5% -$698K ﹤0.01% 2310
2022
Q2
$16.6M Buy
1,124,401
+276,513
+33% +$4.53M ﹤0.01% 2056
2022
Q1
$16.4M Buy
847,888
+411,588
+94% +$7.35M ﹤0.01% 2218
2021
Q4
$7.53M Buy
436,300
+104,138
+31% +$1.77M ﹤0.01% 3023
2021
Q3
$5.55M Buy
332,162
+192,039
+137% +$2.87M ﹤0.01% 3274
2021
Q2
$1.88M Sell
140,123
-655,163
-82% -$8.2M ﹤0.01% 4267
2021
Q1
$9.5M Sell
795,286
-345,151
-30% -$4.17M ﹤0.01% 2611
2020
Q4
$14.1M Sell
1,140,437
-136,040
-11% -$1.47M ﹤0.01% 2159
2020
Q3
$13.3M Sell
1,276,477
-503,264
-28% -$6.4M ﹤0.01% 2071
2020
Q2
$24.9M Buy
1,779,741
+318,999
+22% +$4.34M 0.01% 1497
2020
Q1
$17.2M Buy
1,460,742
+903,768
+162% +$12M 0.01% 1629
2019
Q4
$7.89M Buy
556,974
+307,423
+123% +$3.77M ﹤0.01% 2613
2019
Q3
$2.63M Sell
249,551
-237,072
-49% -$2.83M ﹤0.01% 3351
2019
Q2
$7.08M Sell
486,623
-456,009
-48% -$6.46M ﹤0.01% 2607
2019
Q1
$13.2M Sell
942,632
-283,760
-23% -$4.6M ﹤0.01% 2201
2018
Q4
$21.4M Buy
1,226,392
+55,812
+5% +$906K 0.01% 1760
2018
Q3
$17.8M Sell
1,170,580
-57,504
-5% -$828K ﹤0.01% 2010
2018
Q2
$16.9M Buy
1,228,084
+242,120
+25% +$3.63M ﹤0.01% 2017
2018
Q1
$16.4M Buy
985,964
+42,640
+5% +$658K ﹤0.01% 1991
2017
Q4
$13.4M Sell
943,324
-68,215
-7% -$910K ﹤0.01% 2236
2017
Q3
$14.3M Buy
1,011,539
+350,266
+53% +$4.63M ﹤0.01% 2269
2017
Q2
$8.46M Buy
661,273
+114,678
+21% +$1.44M ﹤0.01% 2639
2017
Q1
$7.56M Buy
546,595
+100,779
+23% +$1.19M ﹤0.01% 2598
2016
Q4
$4.77M Sell
445,816
-737,308
-62% -$7.74M ﹤0.01% 3096
2016
Q3
$13M Buy
1,183,124
+518,454
+78% +$6.05M ﹤0.01% 2240
2016
Q2
$7M Buy
664,670
+516,252
+348% +$6.11M ﹤0.01% 2588
2016
Q1
$1.87M Sell
148,418
-155,381
-51% -$1.7M ﹤0.01% 3541
2015
Q4
$3.2M Buy
303,799
+220,901
+266% +$2.03M ﹤0.01% 3226
2015
Q3
$595K Sell
82,898
-273,416
-77% -$3.72M ﹤0.01% 4970
2015
Q2
$6.44M Buy
356,314
+286,588
+411% +$4.92M ﹤0.01% 2721
2015
Q1
$1.1M Sell
69,726
-159,887
-70% -$2.42M ﹤0.01% 4368
2014
Q4
$3.25M Buy
229,613
+185,910
+425% +$2.79M ﹤0.01% 3382
2014
Q3
$747K Sell
43,703
-447,485
-91% -$10.3M ﹤0.01% 4912
2014
Q2
$14.6M Buy
491,188
+416,876
+561% +$10M ﹤0.01% 2056
2014
Q1
$1.85M Sell
74,312
-27,217
-27% -$797K ﹤0.01% 4043
2013
Q4
$2.92M Sell
101,529
-26,471
-21% -$774K ﹤0.01% 3664
2013
Q3
$4.21M Sell
128,000
-19,647
-13% -$611K ﹤0.01% 3124
2013
Q2
$4.58M Buy
+147,647
New +$3.96M ﹤0.01% 2836

Other funds holding INVA

Goldman Sachs's INVA Position: Q1 2026 in Review

Goldman Sachs increased its Innoviva (INVA) stake by 42% in Q1 2026, buying an estimated $10.2M and bringing the position to 1,593,383 shares worth $37.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1821.

Goldman Sachs first reported a position in INVA in Q2 2013 and has held it in 52 quarters since. 286 funds tracked by Wall St. Rank hold INVA as of Q1 2026.

  • Goldman Sachs held 1,593,383 shares of Innoviva worth $37.1M as of Q1 2026.
  • Goldman Sachs bought 471,412 Innoviva shares in Q1 2026, an estimated $10.2M.
  • Innoviva made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #1821 holding.
  • Goldman Sachs first reported a position in Innoviva in Q2 2013 and has held it in 52 quarters since.
  • 286 funds tracked by Wall St. Rank held Innoviva as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.